🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare the effectiveness of daratumumab wh...
Status
Completed
Location
Multiple Locations
Start Date
2014-07-23
Trial ID
NCT02076009
Treatments Being Tested
This study is being done to find out whether carfilzomib, lenalidomide, and...
Status
Active Not Recruiting
Location
University of Miami
Start Date
2020-02-11
Trial ID
NCT04268498
The purpose of this study is to compare the efficacy of daratumumab in comb...
Status
Completed
Location
Multiple Locations
Start Date
2015-02-16
Trial ID
NCT02252172
Treatments Being Tested
The purpose of this pre-approval access (PAA) program is to provide treatme...
Status
Approved For Marketing
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT04264884
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, and prel...
Status
Completed
Location
Princess Alexandra Hospital Woolloongabba
Start Date
2023-12-12
Trial ID
NCT06055075
Treatments Being Tested
The purpose of this study is to provide ongoing access to study treatments ...
Status
Active Not Recruiting
Location
University of Miami Sylvester Cancer Center
Start Date
2022-12-15
Trial ID
NCT05438043
Treatments Being Tested
The purpose of this study is to evaluate conversion rate to minimal residua...
Status
Completed
Location
University of Alabama Birmingham
Start Date
2019-04-26
Trial ID
NCT03901963
Treatments Being Tested
The purpose of this study is to compare the efficacy of teclistamab daratum...
Status
Active Not Recruiting
Location
University of Alabama Birmingham
Start Date
2021-10-14
Trial ID
NCT05083169
Treatments Being Tested
The primary purpose of this study is to assess the efficacy (overall respon...
Status
Recruiting
Location
Mayo Clinic in Arizona - Phoenix- Site Number : 8400058
Start Date
2025-03-17
Trial ID
NCT06356571
The purpose of this study is to determine if the addition of daratumumab to...
Status
Completed
Location
Multiple Locations
Start Date
2014-12-09
Trial ID
NCT02195479
Treatments Being Tested